30 Day Psychedelic Pharmacology Podcast - Day 17 Blinding, Functional Unblinding, and Placebo Challenges episode artwork

EPISODE · Jan 30, 2025 · 19 MIN

30 Day Psychedelic Pharmacology Podcast - Day 17 Blinding, Functional Unblinding, and Placebo Challenges

from Cannabinoid and Psychedelic Pharmacology and Drug Development

This podcast episode explores the complex challenges of blinding in psychedelic research studies. The discussion delves into why traditional blinding methods often fall short when studying substances like MDMA, LSD, and DMT. Key topics include:- The role of physical indicators like body temperature changes in MDMA studies- How different psychedelics interact with 5HT2A receptors through "functional selectivity"- The influence of set, setting, and participant expectations on study outcomes- The use of active placebos and innovative research methodologies to address blinding challenges

Episode metadata supplied by the publisher feed · Published Jan 30, 2025

Embed this episode

NOW PLAYING

30 Day Psychedelic Pharmacology Podcast - Day 17 Blinding, Functional Unblinding, and Placebo Challenges

0:00 19:40

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Cannabinoid and Psychedelic Pharmacology and Drug Development?

This episode is 19 minutes long.

When was this Cannabinoid and Psychedelic Pharmacology and Drug Development episode published?

This episode was published on January 30, 2025.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Cannabinoid and Psychedelic Pharmacology and Drug Development episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!